Skip to main content
Premium Trial:

Request an Annual Quote

Palex Medical to Distribute Molecular Detection's MRSA Test in Spain

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular Detection and Palex Medical today announced an exclusive agreement, under which Palex will distribute MDI's Detect-Ready MRSA test in Spain.

Palex, a Spanish distributor of medical devices and diagnostic products, recently launched the test in Spain, the companies said in a statement. Financial terms of the deal were not announced.

The Detect-Ready test is a real-time PCR in vitro diagnostic test for the direct detection of methicilllin-resistant Staphylococcus aureus nasal colonization. Unlike other MRSA tests, the Detect-Ready kit are off-the-shelf, room-temperature-stabilized, and require no refrigeration, the two firms said. It also is compatible with several real-time PCR platforms.

In May, MDI and Launch Diagnostics announced a distribution agreement for the test in the UK, France, and Republic or Ireland. The test is also available in Germany, Switzerland, and Austria.

Last month, MDI said it had raised $1.4 million in a follow on to a Series C round of financing.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.